Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.

Treichel AM, Hamieh L, Nathan NR, Tyburczy ME, Wang JA, Oyerinde O, Raiciulescu S, Julien-Williams P, Jones AM, Gopalakrishnan V, Moss J, Kwiatkowski DJ, Darling TN.

Genet Med. 2019 May 22. doi: 10.1038/s41436-019-0520-3. [Epub ahead of print]

PMID:
31114024
2.

Chest CT Scan at Radiation Dose of a Posteroanterior and Lateral Chest Radiograph Series: A Proof of Principle in Lymphangioleiomyomatosis.

Hu-Wang E, Schuzer JL, Rollison S, Leifer ES, Steveson C, Gopalakrishnan V, Yao J, Machado T, Jones AM, Julien-Williams P, Moss J, Chen MY.

Chest. 2019 Mar;155(3):528-533. doi: 10.1016/j.chest.2018.09.007. Epub 2018 Oct 3.

3.

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort.

Gopalakrishnan V, Jones AM, Julien-Williams P, Machado T, Danner RL, Swigris JJ, Paine R 3rd, Lozier JN, Moss J.

ERJ Open Res. 2018 Mar 20;4(1). pii: 00121-2017. doi: 10.1183/23120541.00121-2017. eCollection 2018 Jan.

4.

Rates of change in FEV1 and DLCO as potential indicators for mTOR inhibitor therapy in premenopausal lymphangioleiomyomatosis patients.

Taveira-DaSilva AM, Julien-Williams P, Jones AM, Stylianou M, Moss J.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702258. doi: 10.1183/13993003.02258-2017. Print 2018 Apr.

PMID:
29519926
5.

CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis.

Glasgow CG, Pacheco-Rodriguez G, Steagall WK, Haughey ME, Julien-Williams PA, Stylianou MP, Gochuico BR, Moss J.

Chest. 2018 Feb;153(2):339-348. doi: 10.1016/j.chest.2017.05.018. Epub 2017 May 30.

6.

Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis.

Taveira-DaSilva AM, Jones AM, Julien-Williams P, Stylianou M, Moss J.

Chest. 2018 Jan;153(1):124-132. doi: 10.1016/j.chest.2017.05.012. Epub 2017 May 19.

7.

Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.

El-Chemaly S, Taveira-Dasilva A, Goldberg HJ, Peters E, Haughey M, Bienfang D, Jones AM, Julien-Williams P, Cui Y, Villalba JA, Bagwe S, Maurer R, Rosas IO, Moss J, Henske EP.

Chest. 2017 Jun;151(6):1302-1310. doi: 10.1016/j.chest.2017.01.033. Epub 2017 Feb 10.

8.

Incidence of Pneumothorax in Patients With Lymphangioleiomyomatosis Undergoing Pulmonary Function and Exercise Testing.

Taveira-DaSilva AM, Julien-Williams P, Jones AM, Moss J.

Chest. 2016 Jul;150(1):e5-8. doi: 10.1016/j.chest.2015.10.071.

9.

Effect of fasting on the size of lymphangioleiomyomas in patients with lymphangioleiomyomatosis.

Taveira-DaSilva AM, Jones AM, Julien-Williams P, Shawker T, Glasgow CG, Stylianou M, Moss J.

Chest. 2015 Oct;148(4):1027-1033. doi: 10.1378/chest.15-0456.

10.

Severity and outcome of cystic lung disease in women with tuberous sclerosis complex.

Taveira-DaSilva AM, Jones AM, Julien-Williams P, Yao J, Stylianou M, Moss J.

Eur Respir J. 2015 Jan;45(1):171-80. doi: 10.1183/09031936.00088314. Epub 2014 Dec 23.

11.

Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.

Yao J, Taveira-DaSilva AM, Jones AM, Julien-Williams P, Stylianou M, Moss J.

Am J Respir Crit Care Med. 2014 Dec 1;190(11):1273-82. doi: 10.1164/rccm.201405-0918OC.

12.

Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis.

Taveira-DaSilva AM, Jones AM, Julien-Williams PA, Stylianou M, Moss J.

Chest. 2015 Jan;147(1):180-187. doi: 10.1378/chest.14-0758.

13.

Health insurance status and control of diabetes and coronary artery disease risk factors on enrollment into the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Grogan M, Jenkins M, Sansing VV, MacGregor J, Brooks MM, Julien-Williams P, Amendola A, Abbott JD; BARI 2D Study Group.

Diabetes Educ. 2010 Sep-Oct;36(5):774-83. doi: 10.1177/0145721710374653. Epub 2010 Jun 28.

PMID:
20584997

Supplemental Content

Loading ...
Support Center